Benzinga's Top Downgrades (ALXA, CEO, NBHGY, JAZZ)

Alexza Pharmaceuticals Inc ALXA was downgraded by JMP Securities from "outperform" to "market perform." ALXA's shares closed at $1.38 yesterday. Alexza Pharmaceuticals' trailing-twelve-month ROI is -121.20%. HSBC downgraded CNOOC Limited CEO from "overweight" to "neutral." CEO's stock closed at $213.15 yesterday. CNOOC's earnings may fall 33.53% this year. UBS downgraded Nobel Biocare Holding AG NBHGY from "neutral" to "sell." NBHGY's shares closed at $9.63 yesterday. Nobel Biocare's 52-week trading range is $7.43-$17.14. Jazz Pharmaceuticals Inc JAZZ was downgraded by Jefferies from “buy” to “hold.” JAZZ's shares closed at $10.51 yesterday. JAZZ's quarterly earnings tumbled 341.08% y/y. More Analyst Ratings here